Kezar life sciences, inc. (KZR)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16
Operating expenses:
Research and development

27,363

18,136

6,469

7,373

General and administrative

9,979

6,590

2,280

1,617

Total operating expenses

37,342

24,726

8,749

8,990

Loss from operations

-37,342

-24,726

-8,749

-8,990

Interest income

2,255

1,559

232

-

Net loss

-35,087

-23,167

-8,517

-8,990

Net loss per common share, basic and diluted

-1.84

-2.26

-14.21

-26.56

Weighted-average shares used to compute net loss per common share, basic and diluted

19,083

10,264

599

338